Krishna Kittu Kolluri - Net Worth and Insider Trading

Krishna Kittu Kolluri Net Worth

The estimated net worth of Krishna Kittu Kolluri is at least $1.8 Billion dollars as of 2024-12-27. Krishna Kittu Kolluri is the 10% Owner of iShares Indl/Office Real Estate Capped and owns about 22,603,504 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $721 Million. Krishna Kittu Kolluri is the 10% Owner of Tesaro Inc and owns about 8,854,630 shares of Tesaro Inc (TSRO) stock worth over $664 Million. Krishna Kittu Kolluri is also the 10% Owner of Ra Pharmaceuticals Inc and owns about 3,490,073 shares of Ra Pharmaceuticals Inc (RARX) stock worth over $167 Million. Besides these, Krishna Kittu Kolluri also holds Echo Global Logistics Inc (ECHO) , Ardelyx Inc (ARDX) , Groupon Inc (GRPN) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Epizyme Inc (EPZM) , Juniper Networks Inc (JNPR) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Tableau Software Inc (DATA) , ARYx Therapeutics Inc (ARYX) . Details can be seen in Krishna Kittu Kolluri's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Krishna Kittu Kolluri has not made any transactions after 2016-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Krishna Kittu Kolluri

Krishna Kittu Kolluri Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Krishna Kittu Kolluri owns 45 companies in total, including Achaogen Inc (AKAOQ) , TRACON Pharmaceuticals Inc (TCON) , and Ra Pharmaceuticals Inc (RARX) among others .

Click here to see the complete history of Krishna Kittu Kolluri’s form 4 insider trades.

Insider Ownership Summary of Krishna Kittu Kolluri

Ticker	Comapny	Transaction Date	Type of Owner
AKAOQ	Achaogen Inc	2016-12-19	10 percent owner
TCON	TRACON Pharmaceuticals Inc	2016-11-29	10 percent owner
RARX	Ra Pharmaceuticals Inc	2016-10-31	10 percent owner
		2016-09-21	10 percent owner
		2015-01-26	10 percent owner
		2016-09-14	10 percent owner
		2016-07-29	10 percent owner
		2016-07-18	10 percent owner
		2016-06-14	10 percent owner
		2016-05-13	10 percent owner
		2016-03-18	10 percent owner
		2016-02-03	10 percent owner
		2016-01-12	10 percent owner
		2016-01-01	10 percent owner
		2012-04-30	10 percent owner
		2015-10-14	10 percent owner
		2015-09-30	10 percent owner
		2015-06-16	10 percent owner
		2015-05-27	director & 10 percent owner
		2015-03-11	10 percent owner
		2015-01-22	10 percent owner
		2014-01-30	10 percent owner
		2014-12-02	10 percent owner
		2014-11-25	10 percent owner
		2014-10-08	10 percent owner
		2014-08-27	10 percent owner
		2014-08-06	10 percent owner
		2014-01-29	10 percent owner
		2013-05-22	10 percent owner
		2014-01-09	10 percent owner
		2013-10-29	10 percent owner
		2013-09-11	10 percent owner
		2011-11-21	10 percent owner
		2012-10-11	10 percent owner
		2012-10-29	10 percent owner
		2012-03-28	10 percent owner
		2007-05-30	10 percent owner
		2009-10-01	10 percent owner
		2011-03-10	10 percent owner
		2005-10-26	GM & Security Products Group
		2009-04-03	10 percent owner
		2016-02-10	10 percent owner
		2021-12-30	10 percent owner
		2016-02-10	10 percent owner
		2021-12-30	10 percent owner

Krishna Kittu Kolluri Latest Holdings Summary

Krishna Kittu Kolluri currently owns a total of 17 stocks. Among these stocks, Krishna Kittu Kolluri owns 22,603,504 shares of iShares Indl/Office Real Estate Capped (FNIO) as of February 6, 2012, with a value of $721 Million and a weighting of 39.43%. Krishna Kittu Kolluri owns 8,854,630 shares of Tesaro Inc (TSRO) as of June 3, 2015, with a value of $664 Million and a weighting of 36.31%. Krishna Kittu Kolluri also owns 3,490,073 shares of Ra Pharmaceuticals Inc (RARX) as of October 31, 2016, with a value of $167 Million and a weighting of 9.16%. The other 14 stocks Echo Global Logistics Inc (ECHO) , Ardelyx Inc (ARDX) , Groupon Inc (GRPN) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Epizyme Inc (EPZM) , Juniper Networks Inc (JNPR) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , TRACON Pharmaceuticals Inc (TCON) , Tableau Software Inc (DATA) , ARYx Therapeutics Inc (ARYX) have a combined weighting of 15.11% among all his current holdings.

Latest Holdings of Krishna Kittu Kolluri

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FNIO	iShares Indl/Office Real Estate Capped	2012-02-06	22,603,504	31.89	720,825,743
TSRO	Tesaro Inc	2015-06-03	8,854,630	74.96	663,743,065
RARX	Ra Pharmaceuticals Inc	2016-10-31	3,490,073	47.99	167,488,603
ECHO	Echo Global Logistics Inc	2009-10-01	2,420,219	48.24	116,751,365
ARDX	Ardelyx Inc	2016-07-18	14,083,582	4.81	67,742,029
GRPN	Groupon Inc	2013-09-11	3,709,378	11.97	44,405,706
INWK	InnerWorkings Inc	2012-02-29	6,029,190	2.99	18,027,278
MM	Millennial Media Inc	2012-10-29	8,196,614	1.75	14,344,075
EPZM	Epizyme Inc	2016-01-12	6,260,851	1.47	9,203,451
JNPR	Juniper Networks Inc	2005-10-26	132,124	37.49	4,953,329
DERM	Dermira Inc	2014-10-02	17,241	18.75	323,269
ILIU	Interleukin Genetics Inc	2016-07-29	55,418,811	0.00	249,385
AKAOQ	Achaogen Inc	2016-12-19	5,215,128	0.03	130,378
CLVSQ	Clovis Oncology Inc	2011-11-21	3,419,671	0.02	51,295
TCON	TRACON Pharmaceuticals Inc	2016-11-29	13,790	0.03	444
DATA	Tableau Software Inc	2014-08-22	0	169.53	0
ARYX	ARYx Therapeutics Inc	2011-03-10	0	0.00	0

Holding Weightings of Krishna Kittu Kolluri

Krishna Kittu Kolluri Form 4 Trading Tracker

According to the SEC Form 4 filings, Krishna Kittu Kolluri has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 23,083 shares on February 6, 2012, which brought Krishna Kittu Kolluri around $532,063.

According to the SEC Form 4 filings, Krishna Kittu Kolluri has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the sale of 348 shares on June 3, 2015, which brought Krishna Kittu Kolluri around $20,494.

According to the SEC Form 4 filings, Krishna Kittu Kolluri has made a total of 0 transactions in Ra Pharmaceuticals Inc (RARX) over the past 5 years. The most-recent trade in Ra Pharmaceuticals Inc is the sale of 435 shares on October 31, 2016, which brought Krishna Kittu Kolluri around $5,655.

More details on Krishna Kittu Kolluri's insider transactions can be found in the Insider Trading History of Krishna Kittu Kolluri table.

Insider Trading History of Krishna Kittu Kolluri

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Krishna Kittu Kolluri Trading Performance

GuruFocus tracks the stock performance after each of Krishna Kittu Kolluri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Krishna Kittu Kolluri is 27.31%. GuruFocus also compares Krishna Kittu Kolluri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Krishna Kittu Kolluri within 3 months outperforms 10 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Krishna Kittu Kolluri's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Krishna Kittu Kolluri

Average Return

Average return per transaction

Outperforming Transactions

5 out of 12 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	9.68
Relative Return to S&P 500(%)	9.18

Krishna Kittu Kolluri Ownership Network

Ownership Network List of Krishna Kittu Kolluri

No Data

Ownership Network Relation of Krishna Kittu Kolluri

Krishna Kittu Kolluri Owned Company Details

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Krishna Kittu Kolluri is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does TRACON Pharmaceuticals Inc do?

Who are the key executives at TRACON Pharmaceuticals Inc?

Krishna Kittu Kolluri is the 10 percent owner of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .

TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,200 shares.

TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.

TRACON Pharmaceuticals Inc Insider Transactions

No Available Data

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Krishna Kittu Kolluri is the 10 percent owner of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include director & President and CEO Douglas A Treco , 10 percent owner New Enterprise Associates 13 Lp , and director & 10 percent owner Rajeev M. Shah .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

What does Sorrento Tech Inc do?

Who are the key executives at Sorrento Tech Inc?

Krishna Kittu Kolluri is the 10 percent owner of Sorrento Tech Inc. Other key executives at Sorrento Tech Inc include 10 percent owner Orbimed Capital Gp Iii Llc , 10 percent owner Samuel D Isaly , and 10 percent owner Orbimed Advisors Llc .

Sorrento Tech Inc (ROKA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Tech Inc (ROKA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Tech Inc (ROKA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Tech Inc (ROKA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Tech Inc Insider Transactions

No Available Data

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Krishna Kittu Kolluri is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , director & Chief Executive Officer Steven Lo , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zosano Pharma Corp Insider Transactions

No Available Data

What does Proteostasis Therapeutics Inc do?

Who are the key executives at Proteostasis Therapeutics Inc?

Krishna Kittu Kolluri is the 10 percent owner of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .

Proteostasis Therapeutics Inc (PTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Proteostasis Therapeutics Inc Insider Transactions

No Available Data

What does Interleukin Genetics Inc do?

Who are the key executives at Interleukin Genetics Inc?

Krishna Kittu Kolluri is the 10 percent owner of Interleukin Genetics Inc. Other key executives at Interleukin Genetics Inc include 10 percent owner New Enterprise Associates 14, L.p. , 10 percent owner Growth Equity Opportunities Fund III, LLC , and Interim CFO Stephen J. Dipalma .

Interleukin Genetics Inc (ILIU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interleukin Genetics Inc (ILIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interleukin Genetics Inc (ILIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interleukin Genetics Inc (ILIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Interleukin Genetics Inc Insider Transactions

No Available Data

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Krishna Kittu Kolluri is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include director & President & CEO Michael Raab , Chief Development Officer David P. Rosenbaum , and Chief Medical Officer Laura A Williams .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 397,693 shares made by Michael Raab , a net sale of 304,930 shares made by David P. Rosenbaum , and a net sale of 495,440 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 203,363 shares of Ardelyx Inc (ARDX) in total and bought 429,168 shares, with a net purchase of 225,805 shares. During the past 18 months, 1,995,398 shares of Ardelyx Inc (ARDX) were sold and 429,168 shares were bought by its insiders, resulting in a net sale of 1,566,230 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Opower Inc do?

Who are the key executives at Opower Inc?

Krishna Kittu Kolluri is the 10 percent owner of Opower Inc. Other key executives at Opower Inc include 10 percent owner Scott D Sandell , 10 percent owner M James Barrett , and 10 percent owner Peter J Barris .

Opower Inc (OPWR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Opower Inc (OPWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opower Inc (OPWR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Opower Inc (OPWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opower Inc Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Krishna Kittu Kolluri is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Krishna Kittu Kolluri is the 10 percent owner of Tesaro Inc. Other key executives at Tesaro Inc include director & President & COO Mary Lynne Hedley , SVP & Chief Medical Officer Huber Martin H. Jr. , and director & Chief Executive Officer Moulder Leon O Jr .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

Krishna Kittu Kolluri is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include Chief Technology Officer Michael V. Chobotov , VP Global Sales and Marketing Vivek K Jayaraman , and 10 percent owner New Enterprise Associates 12, Limited Partnership .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Krishna Kittu Kolluri is the 10 percent owner of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epizyme Inc Insider Transactions

No Available Data

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

Krishna Kittu Kolluri is the 10 percent owner of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 70,989 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,531 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,531 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Krishna Kittu Kolluri is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , director & President & CEO Jack A. Khattar , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 120,000 shares made by Padmanabh P. Bhatt , a net sale of 38,886 shares made by Georges Gemayel , and a net sale of 21,235 shares made by Tami Tillotson Martin .

In summary, during the past 3 months, insiders sold 330,917 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 330,917 shares. During the past 18 months, 477,246 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 477,246 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Krishna Kittu Kolluri is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 1,000 shares made by June Sherie Almenoff ,

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 0 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Krishna Kittu Kolluri is the 10 percent owner of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 267 shares made by , and a net sale of 372 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 79 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 79 shares. During the past 18 months, 639 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Krishna Kittu Kolluri is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Aerohive Networks Inc do?

Who are the key executives at Aerohive Networks Inc?

Krishna Kittu Kolluri is the director & 10 percent owner of Aerohive Networks Inc. Other key executives at Aerohive Networks Inc include VP & Gen. Counsel & Secretary Stephen Debenham , SVP & CFO & COO John Ritchie , and 10 percent owner Lightspeed General Partner Vii, L.p. .

Aerohive Networks Inc (HIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerohive Networks Inc (HIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerohive Networks Inc (HIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerohive Networks Inc (HIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerohive Networks Inc Insider Transactions

No Available Data

What does Champions Oncology Inc do?

Who are the key executives at Champions Oncology Inc?

Krishna Kittu Kolluri is the 10 percent owner of Champions Oncology Inc. Other key executives at Champions Oncology Inc include director & President Ronnie Morris , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Roger H Lee .

Champions Oncology Inc (CSBR) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Champions Oncology Inc (CSBR). Other recent insider transactions involving Champions Oncology Inc (CSBR) include a net purchase of 75,504 shares made by Daniel Newman Mendelson ,

In summary, during the past 3 months, insiders sold 0 shares of Champions Oncology Inc (CSBR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Champions Oncology Inc (CSBR) were sold and 75,504 shares were bought by its insiders, resulting in a net purchase of 75,504 shares.

Champions Oncology Inc (CSBR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Champions Oncology Inc Insider Transactions

No Available Data

What does Box Inc do?

Who are the key executives at Box Inc?

Krishna Kittu Kolluri is the 10 percent owner of Box Inc. Other key executives at Box Inc include VP Chief Acct Ofr & Controller Eli Berkovitch , director & 10 percent owner & President & COO Daniel J Levin , and director & 10 percent owner & Chief Financial Officer Dylan C Smith .

Box Inc (BOX) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Box Inc (BOX). Other recent insider transactions involving Box Inc (BOX) include a net sale of 234,000 shares made by Dylan C Smith , a net sale of 70,000 shares made by Aaron Levie , and a net sale of 26,342 shares made by Eli Berkovitch .

In summary, during the past 3 months, insiders sold 250,316 shares of Box Inc (BOX) in total and bought 0 shares, with a net sale of 250,316 shares. During the past 18 months, 704,812 shares of Box Inc (BOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 704,812 shares.

Box Inc (BOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Box Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Krishna Kittu Kolluri is the 10 percent owner of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Tableau Software Inc do?

Who are the key executives at Tableau Software Inc?

Krishna Kittu Kolluri is the 10 percent owner of Tableau Software Inc. Other key executives at Tableau Software Inc include EVP & GC & Secretary Keenan Michael Conder , EVP & Product Development Mark Thomas Nelson , and Executive VP & Sales Kelly Wright .

Tableau Software Inc (DATA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tableau Software Inc (DATA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tableau Software Inc (DATA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tableau Software Inc (DATA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tableau Software Inc Insider Transactions

No Available Data

What does Cvent Inc do?

Who are the key executives at Cvent Inc?

Krishna Kittu Kolluri is the 10 percent owner of Cvent Inc. Other key executives at Cvent Inc include Chief Financial Officer Cynthia A Russo , 10 percent owner Insight Venture Partners Vii, L.p. , and 10 percent owner Insight Venture Partners (delaware) Vii, L.p. .

Cvent Inc (CVT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cvent Inc (CVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cvent Inc (CVT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cvent Inc (CVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cvent Inc Insider Transactions

No Available Data

What does Dermira Inc do?

Who are the key executives at Dermira Inc?

Krishna Kittu Kolluri is the 10 percent owner of Dermira Inc. Other key executives at Dermira Inc include director & Chief Medical Officer Eugene A Bauer , director & CEO & Chairman of the Board Thomas G Wiggans , and CFO Andrew Guggenhime .

Dermira Inc (DERM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dermira Inc (DERM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dermira Inc (DERM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dermira Inc (DERM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dermira Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Krishna Kittu Kolluri is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Loxo Oncology Inc do?

Who are the key executives at Loxo Oncology Inc?

Krishna Kittu Kolluri is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .

Loxo Oncology Inc (LOXO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Loxo Oncology Inc Insider Transactions

No Available Data

What does Care.com Inc do?

Who are the key executives at Care.com Inc?

Krishna Kittu Kolluri is the 10 percent owner of Care.com Inc. Other key executives at Care.com Inc include 10 percent owner Ac/interactivecorp , 10 percent owner Capitalg Gp Llc , and 10 percent owner Capitalg Lp .

Care.com Inc (CRCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Care.com Inc (CRCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Care.com Inc (CRCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Care.com Inc (CRCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Care.com Inc Insider Transactions

No Available Data

What does ChannelAdvisor Corp do?

Who are the key executives at ChannelAdvisor Corp?

Krishna Kittu Kolluri is the 10 percent owner of ChannelAdvisor Corp. Other key executives at ChannelAdvisor Corp include director & Chief Executive Officer M Scot Wingo , Chief Operating Officer Elizabeth Segovia , and President and COO David J Spitz .

ChannelAdvisor Corp (ECOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChannelAdvisor Corp (ECOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChannelAdvisor Corp (ECOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChannelAdvisor Corp (ECOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChannelAdvisor Corp Insider Transactions

No Available Data

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Krishna Kittu Kolluri is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 17,500 shares made by Brian M. Hahn .

In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,271,499 shares of GlycoMimetics Inc (GLYC) were sold and 387,903 shares were bought by its insiders, resulting in a net sale of 1,883,596 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlycoMimetics Inc Insider Transactions

No Available Data

What does Xoom Corp do?

Who are the key executives at Xoom Corp?

Krishna Kittu Kolluri is the 10 percent owner of Xoom Corp. Other key executives at Xoom Corp include 10 percent owner Capital Xi Sequoia , 10 percent owner Sequoia Technology Partners Xi , and 10 percent owner Sequoia Capital Xi Principals Fund .

Xoom Corp (XOOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xoom Corp (XOOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xoom Corp (XOOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xoom Corp (XOOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xoom Corp Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

Krishna Kittu Kolluri is the 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net purchase of 323,344 shares made by Dusan Senkypl , a net purchase of 15,000 shares made by Jason Harinstein , and a net sale of 4,583 shares made by Robert J Bass .

In summary, during the past 3 months, insiders sold 0 shares of Groupon Inc (GRPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,583 shares of Groupon Inc (GRPN) were sold and 338,344 shares were bought by its insiders, resulting in a net purchase of 333,761 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

Krishna Kittu Kolluri is the 10 percent owner of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does Workday Inc do?

Who are the key executives at Workday Inc?

Krishna Kittu Kolluri is the 10 percent owner of Workday Inc. Other key executives at Workday Inc include 10 percent owner David A Duffield , Co-President Sayan Chakraborty , and EVP & General Counsel & Secty Richard Harry Sauer .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 2,420,617 shares made by David A Duffield , a net sale of 19,463 shares made by Douglas A. Robinson , and a net sale of 57,562 shares made by Richard Harry Sauer .

In summary, during the past 3 months, insiders sold 578,830 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 578,830 shares. During the past 18 months, 2,625,117 shares of Workday Inc (WDAY) were sold and 8,676 shares were bought by its insiders, resulting in a net sale of 2,616,441 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does Millennial Media Inc do?

Who are the key executives at Millennial Media Inc?

Krishna Kittu Kolluri is the 10 percent owner of Millennial Media Inc. Other key executives at Millennial Media Inc include VP & Controller & Treasurer Lara Sweet , director & President Robert Lord , and 10 percent owner Verizon Communications Inc .

Millennial Media Inc (MM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millennial Media Inc (MM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millennial Media Inc (MM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millennial Media Inc (MM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millennial Media Inc Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Krishna Kittu Kolluri is the 10 percent owner of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Krishna Kittu Kolluri is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 220,262 shares made by Bradley L Campbell , a net sale of 315,103 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 30,401 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 30,401 shares. During the past 18 months, 773,149 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 773,149 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Krishna Kittu Kolluri is the 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Krishna Kittu Kolluri is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Growth Equity Opportunities Fund, Llc , 10 percent owner Mark W Perry , and 10 percent owner Newhall Charles W Iii .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Juniper Networks Inc do?

Who are the key executives at Juniper Networks Inc?

Krishna Kittu Kolluri is the GM & Security Products Group of Juniper Networks Inc. Other key executives at Juniper Networks Inc include EVP & CFO Kenneth Bradley Miller , EVP Platform Systems Division Rami Rahim , and SVP General Counsel Robert Mobassaly .

Juniper Networks Inc (JNPR) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Juniper Networks Inc (JNPR). Other recent insider transactions involving Juniper Networks Inc (JNPR) include a net sale of 150,000 shares made by Rami Rahim , a net sale of 248,669 shares made by Kenneth Bradley Miller , and a net sale of 5,400 shares made by Anne Delsanto .

In summary, during the past 3 months, insiders sold 0 shares of Juniper Networks Inc (JNPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 612,326 shares of Juniper Networks Inc (JNPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 612,326 shares.

Juniper Networks Inc (JNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Juniper Networks Inc Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Krishna Kittu Kolluri is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 10,637 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,637 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 89,363 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Krishna Kittu Kolluri is the 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

What does Heliogen Inc do?

Who are the key executives at Heliogen Inc?

Krishna Kittu Kolluri is the 10 percent owner of Heliogen Inc. Other key executives at Heliogen Inc include director & Chief Executive Officer William Gross , 10 percent owner Nant Capital, Llc , and CFO and Head of Strategy Sagar Kurada .

Heliogen Inc (HLGN) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Heliogen Inc (HLGN). Other recent insider transactions involving Heliogen Inc (HLGN) include a net purchase of 449,658 shares made by Nant Capital, Llc , a net sale of 442,298 shares made by William Gross , and a net sale of 12,582 shares made by Phyllis W. Newhouse .

In summary, during the past 3 months, insiders sold 12,582 shares of Heliogen Inc (HLGN) in total and bought 0 shares, with a net sale of 12,582 shares. During the past 18 months, 454,880 shares of Heliogen Inc (HLGN) were sold and 449,658 shares were bought by its insiders, resulting in a net sale of 5,222 shares.

Heliogen Inc (HLGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Heliogen Inc Insider Transactions

No Available Data

What does Kineta Inc do?

Who are the key executives at Kineta Inc?

Krishna Kittu Kolluri is the 10 percent owner of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Kineta Inc (KANT) Insider Trades Summary

Over the past 18 months, Krishna Kittu Kolluri made no insider transaction in Kineta Inc (KANT). Other recent insider transactions involving Kineta Inc (KANT) include a net purchase of 7,250 shares made by Raymond J. Bartoszek , a net purchase of 15,000 shares made by Shawn Iadonato , and a net purchase of 6,500 shares made by Craig W. Philips .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KANT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kineta Inc (KANT) were sold and 45,250 shares were bought by its insiders, resulting in a net purchase of 45,250 shares.

Kineta Inc (KANT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kineta Inc Insider Transactions

No Available Data

What does Athena Technology Acquisition Corp do?

Who are the key executives at Athena Technology Acquisition Corp?

Krishna Kittu Kolluri is the 10 percent owner of Athena Technology Acquisition Corp. Other key executives at Athena Technology Acquisition Corp include CFO and Head of Strategy Sagar Kurada , 10 percent owner Prime Movers Lab Fund Ii Lp , and Interim CFO & and CAO Kelly Rosser .

Athena Technology Acquisition Corp (ATHN.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Athena Technology Acquisition Corp (ATHN.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Athena Technology Acquisition Corp (ATHN.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Athena Technology Acquisition Corp (ATHN.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Athena Technology Acquisition Corp Insider Transactions

No Available Data

Krishna Kittu Kolluri Mailing Address

Above is the net worth, insider trading, and ownership report for Krishna Kittu Kolluri. Currently GuruFocus does not have mailing address information for Krishna Kittu Kolluri.

Discussions on Krishna Kittu Kolluri

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.